{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T17:45:11Z","timestamp":1792691111865,"version":"4.5.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2015,2,28]],"date-time":"2015-02-28T00:00:00Z","timestamp":1425081600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pituitary"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1007\/s11102-015-0645-6","type":"journal-article","created":{"date-parts":[[2015,2,27]],"date-time":"2015-02-27T07:04:08Z","timestamp":1425020648000},"page":"188-194","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":92,"title":["Comorbidities in Cushing\u2019s disease"],"prefix":"10.1007","volume":"18","author":[{"given":"S. T.","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. K.","family":"Nieman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. A.","family":"Feelders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,2,28]]},"reference":[{"key":"645_CR1","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1016\/S0140-6736(06)68699-6","volume":"367","author":"J Newell-Price","year":"2006","unstructured":"Newell-Price J, Bertagna X, Grossman AB, Nieman LK (2006) Cushing\u2019s syndrome. Lancet 367:1605\u20131617","journal-title":"Lancet"},{"key":"645_CR2","first-page":"117","volume":"86","author":"J Lindholm","year":"2001","unstructured":"Lindholm J, Juul S, Jorgenson JO, Astrup J, Bjerre P, Feldt-Rasmussen U, Hagen C, Jorgensen J, Kosteljanetz M, Kristensen L, Laurberg P, Schmidt K, Weeke J (2001) Incidence and late prognosis of Cushing\u2019s syndrome: a population based study. J Clin Endocrinol Metab 86:117\u2013123","journal-title":"J Clin Endocrinol Metab"},{"key":"645_CR3","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.1365-2265.1994.tb02486.x","volume":"40","author":"J Etxabe","year":"1994","unstructured":"Etxabe J, Vazquez JA (1994) Morbidity and mortality in Cushing\u2019s disease: an epidemiological approach. Clin Endocrinol (Oxf) 40:479\u2013484","journal-title":"Clin Endocrinol (Oxf)"},{"key":"645_CR4","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/j.1365-2265.2011.04124.x","volume":"75","author":"MJ Bolland","year":"2011","unstructured":"Bolland MJ, Holdaway IM, Berkeley JE, Lim S, Dransfield WJ, Conaglen JV, Croxson MS, Gamble GD, Hunt PJ, Toomath RJ (2011) Mortality and morbidity in Cushing\u2019s syndrome in New Zealand. Clin Endocrinol 75:436\u2013442","journal-title":"Clin Endocrinol"},{"key":"645_CR5","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1530\/EJE-11-0272","volume":"165","author":"E Valassi","year":"2011","unstructured":"Valassi E, Santos A, Yaneva M, Toth M, Strasburger CJ, Chanson P, Wass JA, Chabre O, Pfeifer M, Feelders RA, Tsagarakis S, Trainer PJ, Franz H, Zopf K, Zacharieva S, Lamberts SW, Tabarin A, Webb SM (2011) The European registry on Cushing\u2019s syndrome: 2-year experience. Baseline, demographic and clinical characteristics. Eur J Endocrinol 165:383\u2013392","journal-title":"Eur J Endocrinol"},{"key":"645_CR6","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1210\/jc.2006-2112","volume":"92","author":"OM Dekkers","year":"2007","unstructured":"Dekkers OM, Biermasz NR, Pereira AM, Roelfsema F, van Aken MO, Voormolen JH, Romijn JA (2007) Mortality in patients treated for Cushing\u2019s disease is increased compared to patients treated for nonfunctioning pituitary macroadenomas. J Clin Endocrinol Metab 92:976\u2013981","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"645_CR7","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1530\/EJE-11-1095","volume":"167","author":"RA Feelders","year":"2012","unstructured":"Feelders RA, Pulgar SJ, Kempel A, Pereira AM (2012) The burden of Cushing\u2019s disease: clinical and health-related quality of life aspects. Eur J Endocrinol 167(3):311\u2013326","journal-title":"Eur J Endocrinol"},{"key":"645_CR8","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1210\/jc.2010-1942","volume":"96","author":"RN Clayton","year":"2011","unstructured":"Clayton RN, Raskauskiene D, Reulen RC, Jones PW (2011) Mortality and morbidity in Cushing\u2019s disease over 50\u00a0years in Stokeon-Trent, UK: audit and meta-analysis of literature. J Clin Endocrinol Metab 96:632\u2013642","journal-title":"J Clin Endocrinol Metab"},{"key":"645_CR9","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1210\/jc.2011-2957","volume":"97","author":"ZK Hassan-Smith","year":"2012","unstructured":"Hassan-Smith ZK, Sherlock M, Reulen RC, Arlt W, Ayuk J, Toogood AA, Cooper MS, Johnson AP, Stewart PM (2012) Outcome of Cushing\u2019s disease following transsphenoidal surgery in a single center over 20\u00a0years. J Clin Endocrinol Metab 97:1194\u20131201","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"645_CR10","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.ejim.2011.10.013","volume":"23","author":"D Graversen","year":"2012","unstructured":"Graversen D, Vestergaard P, Stochholm K, Gravholt CH, J\u00f8rgensen JO (2012) Mortality in Cushing\u2019s syndrome: a systematic review and meta-analysis. Eur J Intern Med 23(3):278\u2013282","journal-title":"Eur J Intern Med"},{"issue":"8","key":"645_CR11","first-page":"664","volume":"84","author":"A Colao","year":"1999","unstructured":"Colao A, Pivonello R, Spiezia S, Faggiano A, Ferone D, Filippella M, Marzullo P, Cerbone G, Siciliani M, Lombardi G (1999) Persistence of increased cardiovascular risk in patients with Cushing\u2019s disease after five years of successful cure. J Clin Endocrinol Metab 84(8):664\u2013672","journal-title":"J Clin Endocrinol Metab"},{"key":"645_CR12","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1210\/jc.2012-3754","volume":"98","author":"NM Neary","year":"2013","unstructured":"Neary NM, Booker OJ, Abel BS, Matta JR, Muldoon N, Sinaii N, Pettigrew RI, Nieman LK, Gharib AM (2013) Hypercortisolism is associated with increased coronary arterial atherosclerosis: analysis of noninvasive coronary angiography using multidetector computerized tomography. J Clin Endocrinol Metab 98:2045\u20132052","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"645_CR13","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1359\/jbmr.061010","volume":"22","author":"GM Leong","year":"2007","unstructured":"Leong GM, Abad V, Charmandari E, Reynolds JC, Hill S, Chrousos GP, Nieman LK (2007) Effects of child- and adolescent-onset endogenous Cushing syndrome on bone mass, body composition, and growth: a 7-year prospective study into young adulthood. J Bone Miner Res 22(1):110\u2013118","journal-title":"J Bone Miner Res"},{"key":"645_CR14","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1210\/jc.2009-0766","volume":"94","author":"MJ Barahona","year":"2009","unstructured":"Barahona MJ, Sucunza N, Resmini E, Fern\u00e1ndez-Real JM, Ricart W, Moreno-Navarrete JM, Puig T, Farrerons J, Webb SM (2009) Persistent body fat mass and inflammatory marker increases after long-term cure of Cushing\u2019s syndrome. J Clin Endocrinol Metab 94:3365\u20133371","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"645_CR15","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1210\/jc.2002-021558","volume":"88","author":"A Faggiano","year":"2003","unstructured":"Faggiano A, Pivonello R, Spiezia S, De Martino MC, Filippella M, Di Somma C, Lombardi G, Colao A (2003) Cardiovascular risk factors and common carotid artery caliber and stiffness in patients with Cushing\u2019s disease during active disease and 1\u00a0year after disease remission. J Clin Endocrinol Metab 88(6):2527\u20132533","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"645_CR16","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1111\/j.1365-2265.2004.02168.x","volume":"61","author":"T Mancini","year":"2004","unstructured":"Mancini T, Kola B, Mantero F, Boscaro M, Arnaldi G (2004) High cardiovascular risk in patients with Cushing\u2019s syndrome according to 1999 WHO\/ISH guidelines. Clin Endocrinol (Oxf) 61(6):768\u2013777","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"645_CR17","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0895-7061(95)00299-5","volume":"9","author":"F Fallo","year":"1996","unstructured":"Fallo F, Sonino N, Barzon L, Pistorello M, Pagotto U, Paoletta A, Boscaro M (1996) Effect of surgical treatment on hypertension in Cushing\u2019s syndrome. Am J Hypertens 9(1):77\u201380","journal-title":"Am J Hypertens"},{"key":"645_CR18","first-page":"439","volume":"67","author":"RM G\u00f3mez","year":"2007","unstructured":"G\u00f3mez RM, Albiger NM, D\u00edaz AG, Moncet D, Pitoia FA, Bruno OD (2007) Effect of hypercortisolism control on high blood pressure in Cushing\u2019s syndrome. Medicina (B Aires) 67:439\u2013444","journal-title":"Medicina (B Aires)"},{"key":"645_CR19","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/j.1365-2265.2011.04206.x","volume":"76","author":"PM Toja","year":"2012","unstructured":"Toja PM, Branzi G, Ciambellotti F, Radaelli P, De Martin M, Lonati LM, Scacchi M, Parati G, Cavagnini F, Pecori Giraldi F (2012) Clinical relevance of cardiac structure and function abnormalities in patients with Cushing\u2019s syndrome before and after cure. Clin Endocrinol (Oxf) 76:332\u2013338","journal-title":"Clin Endocrinol (Oxf)"},{"key":"645_CR20","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1016\/S0735-1097(03)00493-5","volume":"41","author":"ML Muiesan","year":"2003","unstructured":"Muiesan ML, Lupia M, Salvetti M, Grigoletto C, Sonino N, Boscaro M, Rosei EA, Mantero F, Fallo F (2003) Left ventricular structural and functional characteristics in Cushing\u2019s syndrome. J Am Coll Cardiol 41:2275\u20132279","journal-title":"J Am Coll Cardiol"},{"key":"645_CR21","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1530\/EJE-09-0621","volume":"162","author":"AM Pereira","year":"2010","unstructured":"Pereira AM, Delgado V, Romijn JA, Smit JW, Bax JJ, Feelders RA (2010) Cardiac dysfunction is reversed upon successful treatment of Cushing\u2019s syndrome. Eur J Endocrinol 162:331\u2013340","journal-title":"Eur J Endocrinol"},{"key":"645_CR22","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/BF03343697","volume":"23","author":"LM Fatti","year":"2000","unstructured":"Fatti LM, Bottasso B, Invitti C, Coppola R, Cavagnini F, Mannucci PM (2000) Markers of activation of coagulation and fibrinolysis in patients with Cushing\u2019s syndrome. J Endocrinol Invest 23:145\u2013150","journal-title":"J Endocrinol Invest"},{"key":"645_CR23","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1210\/jc.2011-2753","volume":"97","author":"R Pas van der","year":"2012","unstructured":"van der Pas R, de Bruin C, Leebeek FW, de Maat MP, Rijken DC, Pereira AM, Romijn JA, Netea-Maier RT, Hermus AR, Zelissen PM, de Jong FH, van der Lely AJ, de Herder WW, Lamberts SW, Hofland LJ, Feelders RA (2012) The hypercoagulable state in Cushing\u2019s disease is associated with increased levels of procoagulant factors and impaired fibrinolysis, but is not reversible after short-term biochemical remission induced by medical therapy. J Clin Endocrinol Metab 97:1303\u20131310","journal-title":"J Clin Endocrinol Metab"},{"key":"645_CR24","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1530\/EJE-10-0583","volume":"163","author":"L Manetti","year":"2010","unstructured":"Manetti L, Bogazzi F, Giovannetti C, Raffaelli V, Genovesi M, Pellegrini G, Ruocco L, Iannelli A, Martino E (2010) Changes in coagulation indexes and occurrence of venous thromboembolism in patients with Cushing\u2019s syndrome: results from a prospective study before and after surgery. Eur J Endocrinol 163:783\u2013791","journal-title":"Eur J Endocrinol"},{"key":"645_CR25","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1210\/jc.2009-0290","volume":"94","author":"B Zaane Van","year":"2009","unstructured":"Van Zaane B, Nur E, Squizzato A, Dekkers OM, Twickler MT, Fliers E, Gerdes VE, B\u00fcller HR, Brandjes DP (2009) Hypercoagulable state in Cushing\u2019s syndrome: a systematic review. J Clin Endocrinol Metab 94:2743\u20132750","journal-title":"J Clin Endocrinol Metab"},{"key":"645_CR26","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1001\/archinte.158.6.585","volume":"158","author":"MD Silverstein","year":"1998","unstructured":"Silverstein MD, Heit JA, Mohr DN, Petterson TM, O\u2019Fallon WM, Melton LJ III (1998) Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med 158:585\u2013593","journal-title":"Arch Intern Med"},{"key":"645_CR27","doi-asserted-by":"crossref","first-page":"3525","DOI":"10.1210\/jc.2011-1661","volume":"96","author":"DJ Stuijver","year":"2011","unstructured":"Stuijver DJ, van Zaane B, Feelders RA, Debeij J, Cannegieter SC, Hermus AR, van den Berg G, Pereira AM, de Herder WW, Wagenmakers MA, Kerstens MN, Zelissen PM, Fliers E, Schaper N, Drent ML, Dekkers OM, Gerdes VE (2011) Incidence of venous thromboembolism in patients with Cushing\u2019s syndrome: a multicenter cohort study. J Clin Endocrinol Metab 96:3525\u20133532","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl 1","key":"645_CR28","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1159\/000314319","volume":"92","author":"R Pivonello","year":"2010","unstructured":"Pivonello R, De Leo M, Vitale P, Cozzolino A, Simeoli C, De Martino MC, Lombardi G, Colao A (2010) Pathophysiology of diabetes mellitus in Cushing\u2019s syndrome. Neuroendocrinology 92(Suppl 1):77\u201381","journal-title":"Neuroendocrinology"},{"key":"645_CR29","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1530\/EJE-13-0754","volume":"170","author":"C Giordano","year":"2013","unstructured":"Giordano C, Guarnotta V, Pivonello R, Amato MC, Simeoli C, Ciresi A, Cozzolino A, Colao A (2013) Is diabetes in Cushing\u2019s syndrome only a consequence of hypercortisolism? Eur J Endocrinol 170:311\u2013319","journal-title":"Eur J Endocrinol"},{"issue":"Suppl 1","key":"645_CR30","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1159\/000314213","volume":"92","author":"G Arnaldi","year":"2010","unstructured":"Arnaldi G, Scandali VM, Trementino L, Cardinaletti M, Appolloni G, Boscaro M (2010) Pathophysiology of dyslipidemia in Cushing\u2019s syndrome. Neuroendocrinology 92(Suppl 1):86\u201390","journal-title":"Neuroendocrinology"},{"issue":"Suppl 1","key":"645_CR31","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1159\/000314294","volume":"92","author":"Y Greenman","year":"2010","unstructured":"Greenman Y (2010) Management of dyslipidemia in Cushing\u2019s syndrome. Neuroendocrinology 92(Suppl 1):91\u201395","journal-title":"Neuroendocrinology"},{"key":"645_CR32","first-page":"671","volume":"84","author":"VM Maher","year":"1992","unstructured":"Maher VM, Trainer PJ, Scoppola A, Anderson JV, Thompson GR, Besser GM (1992) Possible mechanism and treatment of o, p\u2019DDD-induced hypercholesterolaemia. Q J Med 84:671\u2013679","journal-title":"Q J Med"},{"key":"645_CR33","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.clpt.2006.09.003","volume":"80","author":"PJ Neuvonen","year":"2006","unstructured":"Neuvonen PJ, Niemi M, Backman JT (2006) Drug interactions with lipid-lowering drugs: mechanisms and clinical relevance. Clin Pharmacol Ther 80:565\u2013581","journal-title":"Clin Pharmacol Ther"},{"key":"645_CR34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1507\/endocrj.50.1","volume":"50","author":"N Ohmori","year":"2003","unstructured":"Ohmori N, Nomura K, Ohmori K, Kato Y, Itoh T, Takano K (2003) Osteoporosis is more prevalent in adrenal than in pituitary Cushing\u2019s syndrome. Endocr J 50:1\u20137","journal-title":"Endocr J"},{"key":"645_CR35","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1007\/s00198-013-2520-5","volume":"25","author":"L Trementino","year":"2014","unstructured":"Trementino L, Appolloni G, Ceccoli L, Marcelli G, Concettoni C, Boscaro M, Arnaldi G (2014) Bone complications in patients with Cushing\u2019s syndrome: looking for clinical, biochemical, and genetic determinants. Osteoporos Int 25:913\u2013921","journal-title":"Osteoporos Int"},{"key":"645_CR36","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1046\/j.1365-2265.2003.01713.x","volume":"58","author":"C Somma Di","year":"2003","unstructured":"Di Somma C, Pivonello R, Loche S, Faggiano A, Klain M, Salvatore M, Lombardi G, Colao A (2003) Effect of 2\u00a0years of cortisol normalization on the impaired bone mass and turnover in adolescent and adult patients with Cushing\u2019s disease: a prospective study. Clin Endocrinol (Oxf) 58:302\u2013308","journal-title":"Clin Endocrinol (Oxf)"},{"key":"645_CR37","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.ecl.2005.01.014","volume":"34","author":"JL Shaker","year":"2005","unstructured":"Shaker JL, Lukert BP (2005) Osteoporosis associated with excess glucocorticoids. Endocrinol Metab Clin N Am 34:341\u2013356","journal-title":"Endocrinol Metab Clin N Am"},{"key":"645_CR38","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1530\/eje.1.02067","volume":"154","author":"C Kristo","year":"2006","unstructured":"Kristo C, Jemtland R, Ueland T, Godang K, Bollerslev J (2006) Restoration of the coupling process and normalization of bone mass following successful treatment of endogenous Cushing\u2019s syndrome: a prospective, long-term study. Eur J Endocrinol 154:109\u2013118","journal-title":"Eur J Endocrinol"},{"key":"645_CR39","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1365-2265.1992.tb01437.x","volume":"36","author":"PJ Manning","year":"1992","unstructured":"Manning PJ, Evans MC, Reid IR (1992) Normal bone mineral density following cure of Cushing\u2019s syndrome. Clin Endocrinol (Oxf) 36:229\u2013234","journal-title":"Clin Endocrinol (Oxf)"},{"key":"645_CR40","first-page":"2859","volume":"80","author":"AR Hermus","year":"1995","unstructured":"Hermus AR, Smals AG, Swinkels LM, Huysmans DA, Pieters GF, Sweep CF, Corstens FH, Kloppenborg PW (1995) Bone mineral density and bone turnover before and after surgical cure of Cushing\u2019s syndrome. J Clin Endocrinol Metab 80:2859\u20132865","journal-title":"J Clin Endocrinol Metab"},{"key":"645_CR41","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1210\/jc.2002-021494","volume":"88","author":"A Faggiano","year":"2003","unstructured":"Faggiano A, Pivonello R, Melis D, Filippella M, Di Somma C, Petretta M, Lombardi G, Colao A (2003) Nephrolithiasis in Cushing\u2019s disease: prevalence, etiopathogenesis, and modification after disease cure. J Clin Endocrinol Metab 88:2076\u20132080","journal-title":"J Clin Endocrinol Metab"},{"key":"645_CR42","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/j.1365-2265.1995.tb02614.x","volume":"43","author":"LD Dorn","year":"1995","unstructured":"Dorn LD, Burgess ES, Dubbert B, Simpson SE, Friedman T, Kling M, Gold PW, Chrousos GP (1995) Psychopathology in patients with endogenous Cushing\u2019s syndrome: \u2018atypical\u2019 or melancholic features. Clin Endocrinol (Oxf) 43:433\u2013442","journal-title":"Clin Endocrinol (Oxf)"},{"key":"645_CR43","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2165\/00023210-200115050-00003","volume":"15","author":"N Sonino","year":"2001","unstructured":"Sonino N, Fava GA (2001) Psychiatric disorders associated with Cushing\u2019s syndrome. Epidemiology, pathophysiology and treatment. CNS Drugs 15:361\u2013373","journal-title":"CNS Drugs"},{"key":"645_CR44","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1046\/j.1365-2265.1996.8690878.x","volume":"45","author":"WF Kelly","year":"1996","unstructured":"Kelly WF, Kelly MJ, Faragher B (1996) A prospective study of psychiatric and psychological aspects of Cushing\u2019s syndrome. Clin Endocrinol (Oxf) 45:715\u2013720","journal-title":"Clin Endocrinol (Oxf)"},{"key":"645_CR45","first-page":"912","volume":"82","author":"LD Dorn","year":"1997","unstructured":"Dorn LD, Burgess ES, Friedman TC, Dubbert B, Gold PW, Chrousos GP (1997) The longitudinal course of psychopathology in Cushing\u2019s syndrome after correction of hypercortisolism. J Clin Endocrinol Metab 82:912\u2013919","journal-title":"J Clin Endocrinol Metab"},{"key":"645_CR46","doi-asserted-by":"crossref","first-page":"E129","DOI":"10.1210\/jc.2010-0512","volume":"95","author":"J Tiemensma","year":"2010","unstructured":"Tiemensma J, Biermasz NR, Middelkoop HA, van der Mast RC, Romijn JA, Pereira AM (2010) Increased prevalence of psychopathology and maladaptive personality traits after long-term cure of Cushing\u2019s disease. J Clin Endocrinol Metab 95:E129\u2013E141","journal-title":"J Clin Endocrinol Metab"},{"key":"645_CR47","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/0006-3223(92)90079-F","volume":"32","author":"MN Starkman","year":"1992","unstructured":"Starkman MN, Gebarski SS, Berent S, Schteingart DE (1992) Hippocampal formation volume, memory dysfunction, and cortisol levels in patients with Cushing\u2019s syndrome. Biol Psychiatry 32:756\u2013765","journal-title":"Biol Psychiatry"},{"key":"645_CR48","first-page":"21","volume":"13","author":"JN Hook","year":"2007","unstructured":"Hook JN, Giordani B, Schteingart DE, Guire K, Giles J, Ryan K, Gebarski SS, Langenecker SA, Starkman MN (2007) Patterns of cognitive change over time and relationship to age following successful treatment of Cushing\u2019s disease. J Int Neuropsychol Soc 13:21\u201329","journal-title":"J Int Neuropsychol Soc"},{"key":"645_CR49","doi-asserted-by":"crossref","first-page":"E1640","DOI":"10.1210\/jc.2012-1945","volume":"97","author":"O Ragnarsson","year":"2012","unstructured":"Ragnarsson O, Berglund P, Eder DN, Johannsson G (2012) Long-term cognitive impairments and attentional deficits in patients with Cushing\u2019s disease and cortisol-producing adrenal adenoma in remission. J Clin Endocrinol Metab 97:E1640\u2013E1648","journal-title":"J Clin Endocrinol Metab"},{"key":"645_CR50","first-page":"1949","volume":"87","author":"I Bourdeau","year":"2002","unstructured":"Bourdeau I, Bard C, No\u00ebl B, Leclerc I, Cordeau MP, B\u00e9lair M, Lesage J, Lafontaine L, Lacroix A (2002) Loss of brain volume in endogenous Cushing\u2019s syndrome and its reversibility after correction of hypercortisolism. J Clin Endocrinol Metab 87:1949\u20131954","journal-title":"J Clin Endocrinol Metab"},{"key":"645_CR51","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1016\/S0006-3223(99)00203-6","volume":"46","author":"MN Starkman","year":"1999","unstructured":"Starkman MN, Giordani B, Gebarski SS, Berent S, Schork MA, Schteingart DE (1999) Decrease in cortisol reverses human hippocampal atrophy following treatment of Cushing\u2019s disease. Biol Psychiatry 46:1595\u20131602","journal-title":"Biol Psychiatry"},{"key":"645_CR52","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1210\/jc.2009-2032","volume":"95","author":"J Tiemensma","year":"2010","unstructured":"Tiemensma J, Kokshoorn NE, Biermasz NR, Keijser BJ, Wassenaar MJ, Middelkoop HA, Pereira AM, Romijn JA (2010) Subtle cognitive impairments in patients with long-term cure of Cushing\u2019s disease. J Clin Endocrinol Metab 95:2699\u20132714","journal-title":"J Clin Endocrinol Metab"},{"key":"645_CR53","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.nicl.2014.01.017","volume":"4","author":"SJ Werff van der","year":"2014","unstructured":"van der Werff SJ, Andela CD, Nienke Pannekoek J, Meijer OC, van Buchem MA, Rombouts SA, van der Mast RC, Biermasz NR, Pereira AM, van der Wee NJ (2014) Widespread reductions of white matter integrity in patients with long-term remission of Cushing\u2019s disease. Neuroimage Clin 4:659\u2013667","journal-title":"Neuroimage Clin"},{"key":"645_CR54","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0889-8529(18)30087-2","volume":"23","author":"PM Gotch","year":"1994","unstructured":"Gotch PM (1994) Cushing\u2019s syndrome from the patient\u2019s perspective. Endocrinol Metab Clin N Am 23:607\u2013617","journal-title":"Endocrinol Metab Clin N Am"},{"key":"645_CR55","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1210\/jc.2005-1058","volume":"91","author":"JR Lindsay","year":"2006","unstructured":"Lindsay JR, Nansel T, Baid S, Gumowski J, Nieman LK (2006) Long-term impaired quality of life in Cushing\u2019s syndrome despite initial improvement after surgical remission. J Clin Endocrinol Metab 91:447\u2013453","journal-title":"J Clin Endocrinol Metab"},{"key":"645_CR56","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.1210\/jc.2004-1375","volume":"90","author":"MO Aken van","year":"2005","unstructured":"van Aken MO, Pereira AM, Biermasz NR, van Thiel SW, Hoftijzer HC, Smit JW, Roelfsema F, Lamberts SW, Romijn JA (2005) Quality of life in patients after long-term biochemical cure of Cushing\u2019s disease. J Clin Endocrinol Metab 90:3279\u20133286","journal-title":"J Clin Endocrinol Metab"},{"key":"645_CR57","author":"A Carluccio","year":"2014","unstructured":"Carluccio A, Sundaram NK, Chablani S, Amrock LG, Lambert JK, Post KD, Geer EB (2014) Predictors of quality of life in 102 patients with treated Cushing\u2019s disease. Clin Endocrinol (Oxf). doi: 10.1111\/cen.12521","journal-title":"Clin Endocrinol (Oxf)"},{"key":"645_CR58","author":"CD Andela","year":"2015","unstructured":"Andela CD, Scharloo M, Pereira AM, Kaptein AA, Biermasz NR (2015) Quality of life (QoL) impairments in patients with a pituitary adenoma: a systematic review of QoL studies. Pituitary. doi: 10.1007\/s11102-015-0636-7","journal-title":"Pituitary"},{"key":"645_CR59","doi-asserted-by":"crossref","first-page":"681","DOI":"10.4158\/EP10368.OR","volume":"17","author":"B Swearingen","year":"2011","unstructured":"Swearingen B, Wu N, Chen SY, Pulgar S, Biller BM (2011) Health care resource use and costs among patients with cushing disease. Endocr Pract 17:681\u2013690","journal-title":"Endocr Pract"},{"key":"645_CR60","author":"MS Broder","year":"2014","unstructured":"Broder MS, Neary MP, Chang E, Cherepanov D, Ludlam WH (2014) Burden of illness, annual healthcare utilization and costs associated with commercially insured patients with Cushing\u2019s disease in the United States. Endocr Pract. doi: 10.4158\/EP14126.OR","journal-title":"Endocr Pract"}],"container-title":["Pituitary"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-015-0645-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11102-015-0645-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-015-0645-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,21]],"date-time":"2019-08-21T09:51:01Z","timestamp":1566381061000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11102-015-0645-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,28]]},"references-count":60,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["645"],"URL":"https:\/\/doi.org\/10.1007\/s11102-015-0645-6","relation":{},"ISSN":["1386-341X","1573-7403"],"issn-type":[{"value":"1386-341X","type":"print"},{"value":"1573-7403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2,28]]}}}